Survivin mRNA Antagonists Using Locked Nucleic Acid, Potential for Molecular Cancer Therapy

REFERENCES

• Altieri , D. C. 2003 . Validating survivin as a cancer therapeutic target . Nat. Rev. Cancer , 3 : 46 – 54 .
   PubMed Web of Science ®Google Scholar
• Olie , R. A. , Simoes-Wust , A. P. , Baumann , B. , Leech , S. H. , Fabbro , D. , Stahel , R. A. and Zangemeister-Wittke , U. 2000 . A novel antisense oligonucleotide targeting Survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy . Cancer Res. , 60 : 2805 – 2809 .
   PubMed Web of Science ®Google Scholar
• Shinohara , E. T. , Hallahan , D. E. and Lu , B. 2004 . The use of antisense oligonucleotides in evaluating Survivin as a therapeutic target for radiation sensitization in lung cancer . Biol. Proced. Online , 6 : 250 – 256 .
   PubMedGoogle Scholar
• Grunweller , A. , Wyszko , E. , Bieber , B. , Jahnel , R. , Erdmann , V. A. and Kurreck , J. 2003 . Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2′-O-methyl RNA, phosphorothioates and small interfering RNA . Nucleic Acids Res. , 31 : 3185 – 3193 .
   PubMed Web of Science ®Google Scholar
• Wahlestedt , C. , Salmi , P. , Good , L. , Kela , J. , Johnsson , T. , Hokfelt , T. , Broberger , C. , Porreca , F. , Lai , J. , Ren , K. , Ossipov , M. , Koshkin , A. , Jakobsen , N. , Skouv , J. , Oerum , H. , Jacobsen , M. H. and Wengel , J. 2000 . Potent and nontoxic antisense oligonucleotides containing locked nucleic acids . Proc. Natl. Acad. Sci. USA , 97 : 5633 – 5638 .
   PubMed Web of Science ®Google Scholar